Data as of 3:42pm ET
| +0.03 / +0.33%|
The 5 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 3.50. The median estimate represents a +3.94% increase from the last price of 9.14.
The current consensus among 5 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.